CAFs have been reported to be involved in cancer progression through the secretion of growth or pro-inflammatory factors, such as transforming growth factor-β (TGF-β), hepatocyte growth factor (HGF), and C–X–C motif chemokine ligand 12(CXCL12) [26]. This evidence concerns the gene TGFB1 and cancer.